While oral medications are generally considered safer and more convenient than injections or inhalations, sometimes a simple ...

Every year, people around the world take an astonishing 3.8 trillion doses of medicine. Most of these medicines are swallowed ...

Every year, people around the world consume 3.8 trillion doses of medication, an astonishing number. Most of them are ...

Eosinophilic esophagitis is a condition in which certain white blood cells, called eosinophils, are found in the esophagus. It results in pain, difficulty swallowing, and heartburn. Eosinophilic ...

Credit: Phathom Pharmaceuticals. Vonoprazan is an oral small molecule potassium-competitive acid blocker. The Food and Drug Administration (FDA) has approved Voquezna (vonoprazan) for healing and ...

Please provide your email address to receive an email when new articles are posted on . 84% of the Part A cohort and 89.1% of the Part B cohort had an atopic or allergic comorbidity. The most common ...

The 52-week symptom data reported for Cohort 6 patients is consistent with the long-term durability data previously reported ...

When you have an irritated or inflamed esophagus, also known as esophagitis, eating, drinking, and swallowing can be very painful. In most cases, your esophagus will heal on its own, but in the ...

Eosinophilic esophagitis is well documented in children, but the adult form has only recently gained recognition as a distinct entity. Eosinophilic esophagitis was first described in adults by Lee 1 ...

The dynamics of the eosinophilic esophagitis market are anticipated to change in the coming years owing to the expected launch of emerging therapies such as APT-1011 (Ellodi Pharmaceuticals), ...

Eosinophilic esophagitis is a chronic inflammatory condition of the esophagus, or food pipe. The esophagus is the tube that connects the mouth to the stomach. Eosinophilic esophagitis causes chronic ...